Origin Life Sciences, Inc. (OLSI)

Origin Life Sciences will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$4.00 - $6.00
Shares Offered
Deal Size
Chart not available yet
Data will show when the stock starts trading.
Market Cap 194.38M
Revenue (ttm) n/a
Net Income (ttm) -8.84M
Shares Out 38.88M
EPS (ttm) -0.23
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range n/a
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About OLSI

Origin Life Sciences is a clinical-stage biotechnology company that has been developing a proprietary patented high-energy plasma device that generates nitric oxide (“NO”) in the form of a plasma/NO stream and delivers it to targeted locations of the body. The stream can potentially be used for various therapeutic purposes, including as an anti-infective, anti-inflammatory and tissue-regenerative therapy for chronic wounds and skin and soft tissue infections. The U.S. Food and Drug Administration previously determined that our product will be a... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 7
Ticker Symbol OLSI
Full Company Profile

Financial Performance

Financial Statements


Medical device developer Origin Life Sciences files and sets terms for a $15 million IPO

Origin Life Sciences, which is developing a high-energy plasma medical device for dermal and wound care, filed on Monday with the SEC to raise up to $15 million in an initial public offering.

1 week ago - Renaissance Capital

Origin Life Sciences IPO Registration Document (S-1)

Origin Life Sciences has filed to go public with an IPO on the NYSE American.

1 week ago - SEC